"Enabling Genomics in Routine Medical Care"
Workflow
DxDirect™, based on the core NEAT™ technology, dramatically simplifies the testing process. By converting nucleic acid targets (DNA and RNA) into stable substrates, DxDirect™ engineers samples for easy, quantitative amplification and detection using existing instrumentation. When compared to the leading multiplex genomic platforms, DxDirect™ shrinks the number of major process steps from 11 to just 5, without any loss of analytical performance.
This simplified, direct-from-sample process means that, for the first time, complex gene signature testing can be routinely performed by standard lab technicians in one day.
- Features
- Instruments
- Documents
- Direct from primary sample – no target purification
- Easy, 5-step reaction procedure, in just 1 tube, in as little as 1 hour
- Signatures up to 100 genes in a single tube
- Readout using existing instrumentation
- Simultaneous detection of mRNA, SNPs and DNA
- Highly quantitative output
 |
Chemistry White Paper (DxDirect) Data and Background on DxDirect™ and NEAT™ read more... |
||
|
REDI-Dx RUO White Paper |
||
| |
DxCollectTM Sample Collection Product Flyer Sample Collection for Venous or Finger Stick collection read more... |
|
Recent News
DxTerity Presents Direct from Sample Mulitplex Gene Expression in Tissue and FFPE to the American Association of Cancer Researchers read more...
DxTerity wins program with NCI to improve FFPE QC for in situ processing read more...